help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-91-5-1180
Endocrinology Vol. 91, No. 5 1180-1188
Copyright © 1972 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LEE, T. H.
Right arrow Articles by LU, M.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LEE, T. H.
Right arrow Articles by LU, M.-Y.

Effects of {alpha}-MSH on Melanogenesis and Tyrosinase of B-16 Melanoma

TEH H. LEE, MANG S. LEE and MEI-YU LU

Protein Hormone Research Laboratory, Bronx Veterans Administration Hospital and Department of Biochemistry, Albert Einstein College of Medicine Bronx, New York

Abstract

Administration of {alpha}-MSH to C57-BL/6J mice bearing B-16 melanoma induced striking increases in tyrosinase activity and melanogenesis of the tumor. Time course studies on the increases of tyrosinase activity and melanin content of the tumor produced by one injection of {alpha}-MSH indicated that the action of {alpha}-MSH on the melanogenesis of B-16 melanoma is mediated through an increase of tyrosinase activity. Subcellular fractionation of the tumor homogenates by differential centrifugation revealed that the pattern of distribution of tyrosinase activity among the subcellular fractions remained unchanged like that of the controls, when the animals were administered 0.5 mg {alpha}-MSH per mouse per day for 2, 4, 6, 9, 12 and 21 days. This observation is considered incompatible with the hypothesis that a de novo synthesis of the enzyme took place. No tyrosinase activator was detected in the tumor from {alpha}-MSH treated mice. Therefore, it is tentatively concluded that the increase of tyrosinase activity is brought about by the removal of an inhibitor from tie tyrosinase molecules which are present in an inhibited state in the tumor. The nature of the inhibition and the mechanism through which the inhibition was removed, remain obscure at present. (Endocrinology 91: 1180, 1972)

Received March 20, 1972.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
Z Abdel-Malek, V Swope, C Collins, R Boissy, H Zhao, and J Nordlund
Contribution of melanogenic proteins to the heterogeneous pigmentation of human melanocytes
J. Cell Sci., January 12, 1993; 106(4): 1323 - 1331.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1972 by The Endocrine Society